Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits
- 1 September 1996
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 45 (9) , 479-485
- https://doi.org/10.1007/bf02252320
Abstract
Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20–60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30–50%. The treatment also enhanced by 20–40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting delecterious effects of IL-1 by masking the biological activity and by inhibiting the production.Keywords
This publication has 27 references indexed in Scilit:
- Dysregulation of the in vivo production of interleukin‐1 receptor antagonist in patients with rheumatoid arthritis pathogenetic implicationsArthritis & Rheumatism, 1995
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994
- Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.Journal of Clinical Investigation, 1994
- Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCritical Care Medicine, 1994
- Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbitsClinical and Experimental Immunology, 1993
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Modalities for reducing interleukin 1 activity in diseaseImmunology Today, 1993
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Interleukin 1: the first interleukinImmunology Today, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976